Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers

Total article views   Abstract views HTML views PDF downloads Totals
3,021 Dovepress* 2,241 390+ 494 2,631
PubMed Central* 0 390 113 390
Totals 2,241 780 607 3,021
*Since 18 October 2018
+Since July 2016

View citations on PubMed Central and Google Scholar